Health Secretary Wes Streeting has promised to act on her final recommendations, which will be published in June.
Фото: Ken Cedeno / Reuters
。PDF资料对此有专业解读
中国药企依托“工程师红利”在渐进式、改良型创新上取得了大量成果，如今已很少有人质疑中国临床数据的可靠性。其实，世界上划时代的“0到1”新药本就稀少，只要改良分子能切实解决临床痛点，同样被视为全球范围内的有效创新。过去多年的实践与BD交易已证明了这一点。
It is unclear if OpenAI’s reported momentum for Codex can help arrest any decline in other areas of its business or reverse the narrative that it is losing enterprise marketshare to Anthropic.